Bullish Case: Known: CPSH mean-reverts; recent -12.9% week suggests rebound pressure. Inferred from the CPSH IV surface: upside tail implied vol stays relatively elevated into ~1–2 months, matching the return-surface where higher likelihood clusters near modest returns. Known: Helium’s IV forecast is ~4% above market, so realized vol may stay bid even if direction is not strongly signaled. Uncertain: upside depends on whether SPY vol rises too.

Bearish Case: Known: Helium’s price forecast is neutral and its realized/forecast correlation is ~-0.1 (directionally weak). Inferred from the Helium–market uncertainty (difference) surface: downside strikes show the largest positive spread (Helium IV > market), implying downside vol looks comparatively cheaper than the model. Backwardation + elevated near-dated IV suggests risk premia persist into the next CPSH expiry window (~June 18). Uncertain: call-volume dominance (56% > puts) could be hedging/positioning rather than bullish follow-through.

Potential Outcomes:

1. +6% to +12% by Jun-18 (34%): mean-reversion bounce; return-surface density favors modest gains while IV stays supported.
2. -8% to -16% (24%): downside tail break; Helium–market IV spread is strongest in the low-price region.
3. Range -6%/+6% into Jul-17 (30%): spot mean-reverts but IV bleeds if SPY vol cools.
4. Volatility spike (12%): mid-June macro window lifts SPY IV; both tails reprice.

Trading Oracle: Sign Up to access trading oracle trade ideas.

June 05, 2026